Provided By GlobeNewswire
Last update: Aug 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the second quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts.
Read more at globenewswire.com35.98
+0.36 (+1.01%)
Find more stocks in the Stock Screener